GlassScriptPhysician profile
Brandon Tolman
NPI 1992090500
$6,710.40
in general payments reported to CMS, 2019-2025
30 companies · $437 in 2025
The $437 reported for 2025 was more than what 76% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $2,765 · 2021: $101 · 2022: $598 · 2023: $1,132 · 2024: $249 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889 · Travel and Lodging: $807 · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.50 |
| Travel and Lodging | $807.01 |
| Education | $122.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,369.49 | 2019-2025 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $904.14 | 2023 | Iovera, Exparel, Zilretta |
| Collegium Pharmaceutical, INC. | $374.09 | 2019-2022 | |
| Zyla Life Sciences, INC. | $284.10 | 2019-2020 | |
| Flowonix Medical Incorporated | $256.34 | 2019-2020 | |
| Allergan, INC. | $160.49 | 2019-2020 | |
| Globus Medical, INC. | $155.46 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $136.04 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.55 | 2019-2022 | |
| Cerapedics INC. | $119.00 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Scilex Pharmaceuticals INC. | $108.13 | 2020-2022 | |
| Bioventus LLC | $97.91 | 2025 | Gelsyn-3, Xcell |
| Abbvie INC. | $90.55 | 2022-2024 | |
| Pfizer INC. | $74.09 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $62.84 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $51.97 | 2019 | |
| Electronic Waveform Lab, INC. | $41.72 | 2019 | |
| Zavation Medical Products, LLC | $40.05 | 2025 | |
| Medtronic USA, INC. | $35.55 | 2019-2020 | |
| Nevro Corp. | $35.44 | 2019-2023 | Senza |
| Amgen INC. | $29.92 | 2022 | |
| Assertio Therapeutics, INC. | $25.05 | 2019 | |
| Hikma Pharmaceuticals USA | $21.14 | 2022 | |
| Grt US Holding, INC. | $20.21 | 2022 | |
| Organogenesis INC. | $19.66 | 2020 | |
| Smith+Nephew, INC. | $15.67 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Virtus Pharmaceuticals LLC | $13.23 | 2020 | |
| Stryker Corporation | $12.06 | 2019 | |
| Radius Health, INC. | $11.09 | 2020 | |
| Nalu Medical, INC. | $9.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Tolman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.